Similar Articles
551 Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations
552 Cellular based treatment modalities for unresectable hepatocellular carcinoma
553 Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
554 Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients
555 Skeletal muscle metastases of hepatocellular carcinoma: A case report and literature review
556 Biomarkers for hepatocellular carcinoma based on body fluids and feces
557 Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis
558 Radiofrequency ablation vs surgical resection in elderly patients with hepatocellular carcinoma in Milan criteria
559 Prediction of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm based on computed tomography radiomics
560 Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA